166 related articles for article (PubMed ID: 35068172)
21. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
22. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.
Winch CJ; Sherman KA; Boyages J
Breast Cancer Res Treat; 2015 Jan; 149(1):211-21. PubMed ID: 25476499
[TBL] [Abstract][Full Text] [Related]
23. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
24. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.
Houssami N; Abraham LA; Miglioretti DL; Sickles EA; Kerlikowske K; Buist DS; Geller BM; Muss HB; Irwig L
JAMA; 2011 Feb; 305(8):790-9. PubMed ID: 21343578
[TBL] [Abstract][Full Text] [Related]
25. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
26. The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer.
Smith CR; Chiarelli AM; Holloway CM; Mirea L; O'Malley FP; Blackmore KM; Pandya A; Majpruz V; Harris CP; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D
Breast; 2018 Oct; 41():25-33. PubMed ID: 29957557
[TBL] [Abstract][Full Text] [Related]
27. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Chiarelli AM; Blackmore KM; Muradali D; Done SJ; Majpruz V; Weerasinghe A; Mirea L; Eisen A; Rabeneck L; Warner E
J Natl Cancer Inst; 2020 Feb; 112(2):136-144. PubMed ID: 31233143
[TBL] [Abstract][Full Text] [Related]
28. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000.
Chiarelli AM; Halapy E; Nadalin V; Shumak R; O'Malley F; Mai V
Eur J Cancer Prev; 2006 Feb; 15(1):34-42. PubMed ID: 16374227
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
30. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Schousboe JT; Kerlikowske K; Loh A; Cummings SR
Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
[TBL] [Abstract][Full Text] [Related]
31. Factors Associated with Longitudinal Changes in Mammographic Density in a Multiethnic Breast Screening Cohort of Postmenopausal Women.
Park HL; Ziogas A; Feig SA; Kirmizi RL; Lee CJ; Alvarez A; Lucia RM; Goodman D; Larsen KM; Kelly R; Anton-Culver H
Breast J; 2023; 2023():2794603. PubMed ID: 37881237
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
33. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
Stefanick ML; Anderson GL; Margolis KL; Hendrix SL; Rodabough RJ; Paskett ED; Lane DS; Hubbell FA; Assaf AR; Sarto GE; Schenken RS; Yasmeen S; Lessin L; Chlebowski RT;
JAMA; 2006 Apr; 295(14):1647-57. PubMed ID: 16609086
[TBL] [Abstract][Full Text] [Related]
34. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
35. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
[TBL] [Abstract][Full Text] [Related]
36. Mammographic features associated with interval breast cancers in screening programs.
Boyd NF; Huszti E; Melnichouk O; Martin LJ; Hislop G; Chiarelli A; Yaffe MJ; Minkin S
Breast Cancer Res; 2014 Aug; 16(4):417. PubMed ID: 25346388
[TBL] [Abstract][Full Text] [Related]
37. Population Attributable Risk of Advanced-Stage Breast Cancer by Race and Ethnicity.
Kerlikowske K; Chen S; Bissell MCS; Lee CI; Tice JA; Sprague BL; Miglioretti DL
JAMA Oncol; 2024 Feb; 10(2):167-175. PubMed ID: 38060241
[TBL] [Abstract][Full Text] [Related]
38. The natural history of invasive breast cancers detected by screening mammography.
Zahl PH; Maehlen J; Welch HG
Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
[TBL] [Abstract][Full Text] [Related]
39. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
[TBL] [Abstract][Full Text] [Related]
40. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]